Protein-protein interaction (PPI) analysis identified AKT1, VEGFR, HSP90AA1, BCL2, and SRC as hub genes potentially pivotal in the treatment of GBM (Fig. 7B). The gene discussed is AKT1; the disease is glioblastoma.